Daniel J. Durand

Daniel J. Durand is the Chief Medical Officer and President of Prenuvo Medical Group, leading advancements in MRI technology for early disease detection since May 2024. Additionally, Daniel serves as a Clinical Associate Professor at Stanford University School of Medicine and an Adjunct Associate Professor at The George Washington University School of Medicine and Health Sciences. Among various advisory roles, Daniel has been a key opinion leader with RapidAI and provided consulting for several health and technology companies. Previous executive positions include Chief Clinical Officer, Chief Innovation Officer, and Chair of Radiology at LifeBridge Health. Daniel holds an M.D. and multiple degrees from The Johns Hopkins University School of Medicine, as well as a B.S. from Wake Forest University and an Executive MBA with Honors from the Quantic School of Business and Technology.